of an inhibitor of T cell proliferation or from the failure Current Biology 2001, 11:273-276 to produce an essential growth factor. To distinguish be- 
S1 in the Supplementary material available with this article on the internet), and this finding indicates that prolif-
In contrast to another study [6] , p53 deficiency did not rescue mitogen-induced proliferation of FADDeration is dependent on exposure to OVA.
Proliferation of FADD-DN OT-I T cells in the renal and pancreatic

DN T cells, and neither did enforced expression of the apoptosis inhibitor Bcl-2. Like wild-type T cells, lymph nodes was impaired, as only 15%-37% of the cells had a reduced CFSE fluorescence intensity compared to
FADD-DN T cells stimulated with mitogens mobilized intracellular calcium and activated
66%-67% of OT-I T cells. In FADD-DN T cell cultures stimulated with mitogens, those few T cells expressing members of the NF-B transcription factor family as well as p38 mitogen-activated protein kinase low or undetectable levels of FADD-DN protein will proliferate normally [5] . Therefore, the FADD-DN OT-I whole animal as well as mitogen-induced proliferation of T cells in culture. The failure of FADD-DN T cells to
Results and discussion
The effect of FADD-DN expression on T cell prolifera-T cells. When equal numbers of Ly5.1 ϩ control T cells and Ly5. (p53 Ϫ/Ϫ or p53 ϩ/ϩ ; Figure 2 ). We therefore conclude that p53 is not essential for the impaired proliferation of FADD-DN T cells.
To determine whether an inhibitor of apoptosis might rescue the proliferation of FADD-DN T cells, we crossed FADD-DN mice with bcl-2 transgenic mice [12] . FADD-DN/bcl-2 doubly transgenic T cells resembled FADD-DN T cells in their response to mitogens. For example, after 3 days of stimulation with PMA and ionomycin, control and bcl-2 transgenic T cells had reached approximately 1 ϫ 10 6 viable cells/mL from a starting density of 1 ϫ 10 5 cells/mL. In contrast, FADD-DN and FADD-DN/bcl-2 T cells showed little sign of proliferation, and more than 50% of the cells were apoptotic ( Figure S2 in the Supplementary material). Functional Bcl-2 was expressed in the FADD-DN/bcl-2 T cells because, like bcl-2 T cells, their spontaneous death in culture was delayed significantly ( Figure S2 ). Enforced Bcl-2 expression is therefore unable to rescue the proliferation of FADD-DN T cells or to prevent their death after they fail to proliferate.
Mitogen-stimulated FADD-DN T cells do not proliferate because of a
T cell activation after the triggering of the TCR/CD3
cell-autonomous defect in intracellular signaling. crosslinking antibodies to CD3, we labeled purified con- with the Ca 2ϩ ionophore ionomycin showed increases in cells/mL. In contrast, live Ly5.2 ϩ FADD-DN T cells intracellular Ca 2ϩ equivalent to those in control T cells were fewer in number than they were at the start of (Figure 3b ). These results indicate that the proliferaan experiment (Figure 1b) . In control experiments, both tive defect of FADD-DN T cells cannot be attributed wild-type Ly5.1 ϩ and wild-type Ly5.2 ϩ T cells proliferto impaired Ca 2ϩ mobilization following stimulation of ated in response to mitogens (Figure 1b) . These results the TCR. indicate that mitogen-stimulated FADD-DN T cells do not proliferate because of a cell-autonomous defect in Mitogenic stimuli for T cells initiate signaling pathways intracellular signaling.
that activate members of the NF-B family of transcription factors [14] . Given that several death receptors that recruit FADD can signal NF-B activation [1, 2] and that It has been reported that p53 deficiency rescues the proliferation of FADD-DN T cells [6] . We stimulated purified T cells lacking certain NF-B family members do not respond to mitogens [15], we examined NF-B DNA CD4 ϩ or CD8 ϩ T cells from p53-deficient FADD-DN mice with PMA and ionomycin or with crosslinking antibinding activity in mitogen-stimulated FADD-DN T cells by gel shift assays (Figure 4a ). Resting T cells from bodies to CD3 and CD28, and we found that the cells were indistinguishable from FADD-DN T cells express-FADD-DN mice or their nontransgenic littermates contained two nuclear complexes that bound to the B3 binding wild-type p53. After 3-4 days of stimulation, cultures of nontransgenic T cells incorporated three to eight times ing site from the murine rel promoter (Figure 4a, lane 4) . These complexes were upregulated in both control and more (Fig- and ionomycin. Consistent with this being an important signaling event, the p38 MAPK inhibitor SB203580 was ure 4a, lanes 1-3), and these results confirm the DNA binding specificity of the complexes. Antibodies recognizshown to suppress mitogen-induced T cell proliferation [16] . To determine whether p38 MAPK activity is altered ing Rel, RelA, or NF-B1 supershifted the NF-B complexes from control and FADD-DN T cells in a similar in FADD-DN T cells, we performed Western blot analysis of purified control and FADD-DN T cells by using manner (Figure 4a, lanes 7-15) , which indicates that the NF-B complexes did not differ in their subunit composiantibodies that specifically recognize the active, dually phosphorylated form of p38 MAPK (Figure 4b ). Increased tion. These results indicate that the proliferative defect phosphorylated p38 MAPK was detected in both control and FADD-DN T cells after 15 min of stimulation with PMA and ionomycin ( Figure 4b ) or with crosslinking antibodies to CD3 and CD28 (data not shown). Levels of phosphorylated p38 MAPK remained elevated after 4 hr of stimulation but had returned to levels seen in resting T cells after 22 hr. We also examined whether FADD-DN T cells activate p44 and p42 MAPKs like control T cells do. Active, phosphorylated p44 and p42 MAPK were detected in control and FADD-DN T cells after 30 min of stimulation with PMA and ionomycin (Figure 4b ). Levels of phosphorylated p44 and p42 MAPK peaked after 1-2 hr of stimulation and then gradually diminished. Control and FADD-DN T cells also showed equivalent p44 and p42 MAPK activation after CD3 and CD28 ligation (data not shown). Therefore, the failure of FADD-DN T cells to proliferate in response to mitogens is not because FADD is essential for p44 and p42 MAPK activation.
In conclusion, we have established that FADD-DN T cells cannot proliferate after stimulation with mitogens or antigen because of a cell-autonomous defect in intracellu- 
